2022
DOI: 10.1111/imj.15670
|View full text |Cite
|
Sign up to set email alerts
|

Impact of COVID‐19 on the worsening crisis of chronic kidney disease: the imperative to fund early detection is now

Abstract: The number of Australians affected by kidney disease will increase as the impacts of COVID-19 infection on kidney health are realised. Chronic kidney disease (CKD) imposes significant health and economic burdens from dialysis costs, loss of employment, premature death and increased admissions to hospital. Screening for kidney disease must be integrated into post-COVID-19 care; however, currently there is no reimbursement for kidney health checks in primary care. Early detection can reduce the progression of CK… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
3

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 16 publications
0
0
0
Order By: Relevance
“…A ten-fold increase in mortality rates was observed in patients with chronic kidney disease (CKD) and COVID-19 compared with CKD patients without COVID-19. The higher exposure rates to healthcare facilities in patients undergoing maintenance dialysis treatment is a potential factor contributing to the higher incidence of COVID-19 infections in these patients [63]. A study by Chen et al focused on identifying the higher-risk comorbidities and fragile populations among Omicron patients, who were hospitalized.…”
Section: Renal Diseasesmentioning
confidence: 99%
“…A ten-fold increase in mortality rates was observed in patients with chronic kidney disease (CKD) and COVID-19 compared with CKD patients without COVID-19. The higher exposure rates to healthcare facilities in patients undergoing maintenance dialysis treatment is a potential factor contributing to the higher incidence of COVID-19 infections in these patients [63]. A study by Chen et al focused on identifying the higher-risk comorbidities and fragile populations among Omicron patients, who were hospitalized.…”
Section: Renal Diseasesmentioning
confidence: 99%